Week 16 follow-up data, coupled with blinded exit interviews conducted up to 364 days after the study period, confirm durable ...
NervGen will meet with the FDA early next year to align on a regulatory path forward for NVG-291 in chronic spinal cord ...
Northwestern Medicine investigators have developed a new imaging approach to more accurately assess blood flow in the spinal ...
Traumatic spinal cord injuries significantly increase the risk of developing chronic conditions like diabetes, high blood ...
The FDA has cleared home use of a device that helps people with spinal cord injuries regain mobility and functioning.
From Dachshunds to large breeds, managing disc disease requires us to be masters of nuance, neurology, and owner psychology.
Researchers at Children's Hospital of Philadelphia (CHOP) and Children's National Hospital in Washington D.C. are uncovering ...
Onward Medical announced today that it received FDA 510(k) clearance to expand the ARC-EX system's indication for home use.
Medical Device Network on MSN
FDA clears Onward’s ARC-EX System for home use in spinal cord injury care
The US Food and Drug Administration (FDA) has granted 510(k) clearance for the expanded use of Onward Medical’s ARC-EX System ...
Ventoux Biosciences is a biotechnology company developing locally delivered therapies for immune-fibrotic diseases. Founded by a patient with Dupuytren's disease and led by seasoned biotech executives ...
Liverpool specialist nurse and Manchester Arena bombing survivor were on hand for advice as Tyrone undergoes physio after hit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback